VivoSeq
Psychiatry

Post-Traumatic Stress Disorder, PTSD

0

Pipeline Programs

6

Active Trials

4

Companies Involved

Post-Traumatic Stress Disorder, PTSD is an early-stage landscape with 0 programs across 4 companies. The most active players are Columbia Northwest Pharmaceuticals, Lundbeck, GSK.

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

78/100

Attrition Rate

15/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

52

clinical trials

Completed29 · 56%
Unknown status9 · 17%
Recruiting5 · 10%
Terminated5 · 10%
Withdrawn3 · 6%
Not yet recruiting1 · 2%

Trial Activity

52 trials

Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)